Healthcare entity
Every one of those 1 sits in a single category, market-trends. Pharming Group N.V. is most often covered alongside Joenja, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window.
Last mentioned: Mar 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. Pharming Group N.V. is most often covered alongside Joenja, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 5.9 in the same window. Pharming Group N.V. appears in 1 tracked Healthcare story from March 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 38 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Pharming Group N.V.. Shared-story counts are live from our verified record — not editorial picks.
Pharming Group N.V. has surpassed revenue expectations for the latest quarter, driven by strong performance in its rare disease portfolio. The company also introduced a positive fiscal year 2026 outlook, signaling confidence in the continued expansion of its primary treatments for hereditary angioedema and APDS.
Source: Seeking Alpha · Seeking Alpha
Pharming Group N.V. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
